Androgen receptor expression predicts different clinical outcomes for breast cancer patients stratified by hormone receptor status.
Androgen receptor expression predicts different clinical outcomes for breast cancer patients stratified by hormone receptor status.
复制标题
DOI:
10.18632/oncotarget.9778
复制
发表时间:
2016-07-05
期刊:
影响因子:
--
通讯作者:
Shao ZM
中科院分区:
文献类型:
--
作者:
Jiang HS;Kuang XY;Sun WL;Xu Y;Zheng YZ;Liu YR;Lang GT;Qiao F;Hu X;Shao ZM
In this study we sought to correlate androgen receptor (AR) expression with tumor progression and disease-free survival (DFS) in breast cancer patients. We investigated AR expression in 450 breast cancer patients. We found that breast cancers expressing the estrogen receptor (ER) are more likely to co-express AR compared to ER-negative cancers (56.0% versus 28.1%, P < 0.001). In addition, we found that AR expression is correlated with increased DFS in patients with luminal breast cancer (P < 0.001), and decreased DFS in TNBC (triple negative breast cancer, P = 0.014). In addition, patients with HR+ tumors (Hormone receptor positive tumors) expressing low levels of AR have the lowest DFS among all receptor combinations. We also propose a novel prognostic model using AR receptor status, BRCA1, and present data showing that our model is more predictive of disease free survival compared to the traditional TMN staging system.
登录
查看更多内容
DOI:
10.1158/1078-0432.ccr-10-2021
发表时间:
2011-04-01
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Hu R;Dawood S;Holmes MD;Collins LC;Schnitt SJ;Cole K;Marotti JD;Hankinson SE;Colditz GA;Tamimi RM
通讯作者:
Tamimi RM
DOI:
10.1073/pnas.0503793102
发表时间:
2005-06-28
影响因子:
11.1
作者:
Furuta, S;Jiang, XZ;Lee, WH
通讯作者:
Lee, WH
影响因子:
82.9
作者:
Kononen, J;Bubendorf, L;Kallioniemi, OP
通讯作者:
Kallioniemi, OP
DOI:
10.1038/nrm2831
发表时间:
2010-02
期刊:
Nature reviews. Molecular cell biology
影响因子:
--
作者:
通讯作者:
--
影响因子:
3.7
作者:
Choi, Jung Eun;Kang, Su Hwan;Bae, Young Kyung
通讯作者:
Bae, Young Kyung